Skip to Main Content

Try STAT+ TODAY

ethics

Here’s the latest on ethics in medicine, science and technology. Topics include gene editing, artificial intelligence, the use of big data in health care, potential conflicts of interest and an array of moral quandaries.

Most Read

First Opinion Karen Glanz and Holly Fernandez Lynch

‘Three Identical Strangers’: It’s not too late to address the ethical violations

In the Lab Usha Lee McFarling

International team creates first chimeric human-monkey embryos

In the Lab Megan Molteni

Setting aside the thorniest issues around CRISPR babies, scientists say embryo-editing research should proceed

First Opinion Sam Weiss Evans and David Gillum

The lab leak conversation shows it’s time to rethink our biosecurity infrastructure, not just policies

First Opinion Sarah C. Hull

Not so conscientious objection: When can doctors refuse to treat?

First Opinion Robert Truog

New guidelines on severe brain injury complicate already difficult decisions

Health Andrew Joseph

A baby with a disease gene or no baby at all: Genetic testing of embryos creates an ethical morass

First Opinion I. Glenn Cohen and Alex Pearlman

Creating eggs and sperm from stem cells: the next big thing in assisted reproduction?

All Coverage

In the Lab Megan Molteni

STAT Plus: Mice with two fathers and base-edited baby monkeys highlight potential — and limitations — of hereditable gene editing

In the Lab Megan Molteni

STAT Plus: Ahead of genome summit in London, questions linger about CRISPR baby scandal

advertisement

In the Lab Jonathan Wosen

‘It is a balance’: Scientists grapple with ethics of cutting-edge stem cell research

Health Care Amanda Seitz — Associated Press

U.S. plans crackdown on nursing homes that sedate patients with unnecessary antipsychotics

Health Adam Beam — Associated Press

California’s dark history of forced sterilizations comes into focus as it seeks victims to pay reparations

Health Usha Lee McFarling

Paying research participants — a lot — may be a key to increasing diversity in studies

In the Lab Andrew Joseph

Science, Cell issue notices of concern on challenged papers co-authored by Stanford president

In the Lab Damian Garde

Amid criticism, Stanford turns over review of its president to outside investigator

Health Tech Brittany Trang

Twitter has spent years trying to combat health misinformation. Will Musk’s takeover make that harder?

Hospitals Tara Bannow and Kate Sheridan

Harassment prompts children’s hospitals to strip websites, threatening access to gender-affirming care

Special Report Olivia Goldhill

STAT Plus: Tobacco giant Philip Morris is investing billions in health care. Critics say it’s peddling cures for its own poison

First Opinion S. Monica Soni

People with terminal cancer need to know they are dying. Doctors shouldn’t withhold that information

First Opinion Chad Childers

Nazi-tainted Pernkopf’s Atlas: A case for acknowledgement, not removal

First Opinion Holly Fernandez Lynch, Steven Joffe and Emily A. Largent

‘Is an abortion medically necessary?’ is not a question for ethicists to answer

First Opinion Mandeep Dhaliwal

Decriminalizing HIV: Scientifically proven and morally correct

First Opinion Klaudia Jaźwińska

Implant recipients shouldn’t be left in the dark when a device maker cuts off support

First Opinion Hans Gutbrod

Addressing institutional trauma in health care: the case for a structured ethical framework

Exclusive Megan Molteni

Researchers revive abandoned technique in effort to make artificial human eggs in a test tube

First Opinion Irene Shapiro

The Morris ALS Principles: A model for empowering all disease communities

First Opinion Barron H. Lerner

Arthur Ashe and AIDS: Did the public have the right to know his diagnosis?

In the Lab Megan Molteni

Buffalo shooting ignites a debate over the role of genetics researchers in white supremacist ideology

First Opinion Anand Kumar

STAT Plus: Exploitation in the name of biomedical innovation cannot be tolerated

First Opinion Els Torreele

Global health should not be determined by pharma investors and shareholders

The Pharmalot View Ed Silverman

STAT Plus: When should drugmakers go all in and cut off essential medicines to Russia?

Exclusive Megan Molteni

STAT Plus: New details emerge about a U.S. scientist’s obscured role in the ‘CRISPR babies’ scandal